Bright Peak Therapeutics, Inc. — Form D
Bright Peak Therapeutics, Inc. of Del Mar, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-11. The offering totals $90.0M, of which $90.0M was reported sold. Industry: Other.
Offering
- Filed: 2024-06-11
- Form: D
- Accession: 0001813343-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $90.0M
- Amount sold: $90.0M
- Investors: 21
- Date of first sale: 2024-05-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515688
Issuer
- Name: Bright Peak Therapeutics, Inc.
- CIK: 0001813343
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2010 Jimmy Durante Blvd, Del Mar, CA, 92014
- Phone: 626-298-0609
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Jacob Chacko | Director | Del Mar, CA |
| Leena Gandhi | Director | Del Mar, CA |
| Emily Minkow | Director | Boston, MA |
| Laura Shawver | Director | Del Mar, CA |
| Christine Siu | Director | Del Mar, CA |
| Fredrik Wiklund | Director | Del Mar, CA |
| Tom Woiwode | Director | Del Mar, CA |
| Asish Xavier | Director | South San Francisco, CA |
| Bertolt Kreft | Executive Officer | Del Mar, CA |
| Vijaya Pattabiraman | Executive Officer | Del Mar, CA |
| Matthew Robbins | Executive Officer | Del Mar, CA |
| Jon Wigginton | Executive Officer | Del Mar, CA |
| Fredrik Wiklund | Executive Officer | Del Mar, CA |
| Alexander Mayweg | Director | South San Francisco, CA |
| Josh Resnick | Director | Walthum, MA |
| Michael Rosenzweig | Director | San Diego, CA |
Other filings by this issuer (1)
More